Prefilled Syringes Drug Molecules Market is projected to expand at a CAGR of 5.6% during 2022-2028: FMI

Prefilled Syringes Drug Molecules Market is projected to expand at a CAGR of 5.6% during 2022-2028: FMI

PR Newswire

DUBAI, UAE, Jan. 10, 2022

The latest study by Future Market Insight (FMI) provides insights into the governing factors facilitating the growth in the Prefilled Syringes Drug Molecules Market. Ease of Using Prefilled Syringes to Fuel the Growth of the Market

DUBAI, UAE, Jan. 10, 2022 /PRNewswire/ -- A new research report by Future Market Insights titled "Prefilled Syringes Drug Molecules Market" briefs the scenario of the global prefilled syringes drug molecules market which is set to be valued at US$ 56 Bn in 2022, and is projected to expand at a CAGR of 5.6% to close in on a valuation of US$ 77.7 Bn by 2028.

FMI Logo

Prefilled syringes drug molecules are prefilled with medication by the manufactures and are supplied to end users in the ready-to-use form. The overall global investment in healthcare has increased in the last few years. Healthcare field solutions continue to be sought after to increase the quality of life, which provides significant opportunities for pharmaceutical companies. This has also contributed to the growth of various segments of the healthcare industry such as the prefilled syringes drug molecules market.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-3198   

Global Prefilled Syringes Drug Molecules Market: Drivers and Opportunities

The report indicates that revenue growth of the market is mainly driven by the effectiveness, convenience and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringes. In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings have increased the demand for prefilled syringes drug molecules.

Manufacturers are focussing on introducing updated technologies and advanced products in order to attract customers. Pharmaceutical companies are introducing generic versions for cost-effective auto-injector devices and are targeting emerging regions such as the Asia Pacific, Middle East and others in order to sustain and grow in the global prefilled syringes drug molecules market. 

Get a Tailored Scope to Match Your Need, Ask an Expert - https://www.futuremarketinsights.com/ask-question/rep-gb-3198   

Global Prefilled Syringes Drug Molecules Market: Segmental Analysis

On the basis of region, North America is expected to lead the market with a huge margin. The North America prefilled syringes drug molecules market is expected to reach a market valuation of over US$ 23,000 Mn by the end of 2028, growing at a CAGR of 6.2% during the forecast period.

On the basis of drug class, vaccines and insulin are anticipated to show quite similar forecast with a high revenue share and CAGR

On the basis of application, immunisation dominates the global prefilled syringes drug molecules market with its projected revenue share. However, diabetes leads in terms of growth rate with 6.6% CAGR during the forecast period.

In terms of end users, hospital pharmacies are expected to lead the global market with a market revenue of over US$ 32,000 Mn by 2028. However, online pharmacies are projected to register a higher growth rate of 6.2% during the forecast period.

Global Prefilled Syringes Drug Molecules Market: Competitive Landscape

This comprehensive research report consists of a brief profile of all the major players in the industry. Some of the top companies featured in the report are Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG etc.

The global prefilled syringes drug molecules market is highly competitive due to the presence of well-established top players. However, brands such as EpiPen auto Injector and BD Physioject disposable auto injector have strategically maintained their position in the market owing to a distinctive value proposition such as providing more precision and accurate dosage.

For critical insights, Get Customized Report as per your Requirements - https://www.futuremarketinsights.com/customization-available/rep-gb-3198

Key Segments of Prefilled Syringes Drug Molecules Industry Research

By Drug Class:

By Application:

By End User:

By Region:

For in-depth competitive analysis, Buy Now - https://www.futuremarketinsights.com/checkout/3198

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com 
For Media Enquiries: press@futuremarketinsights.com 
Website: https://www.futuremarketinsights.com/ 
Report - https://www.futuremarketinsights.com/reports/prefilled-syringes-drug-molecules-market 
Press Release Source: https://www.futuremarketinsights.com/press-release/prefilled-syringes-drug-molecules-market

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg 

Voltar noticias em Inglês